A “micro-tap” for treating glaucoma

Share via AddThis
Posted on March 26, 2013

A tiny, EPFL-designed implantable device that can be positioned within the eye and controlled remotely may well revolutionize the treatment of glaucoma. The device should be through testing this year and on its way to the market in 2014 via Rheon Medical, an EPFL spin-off.

Glaucoma is the second leading cause of blindness globally, after cataracts. It is characterized by the presence of too much liquid between the cornea and the iris. This leads to a build-up of pressure within the eye, a situation that can destroy the optic nerve if it is not handled correctly.

Read more at: EPFL



44,434 science & technology articles

Categories

Our Articles (see all)

General News

Follow us

Facebook   Twitter   Pinterest   StumbleUpon   Plurk
Google+   Tumblr   Delicious   RSS   Newsletter via Email

Featured Video (see all)


Batteries for the Future: What’s Possible?
Increased demand for energy storage in consumer electronics, electric vehicles and the power grid presents opportunities and challenges…

Featured Image (see all)


Space Image: Streaming Push and Pull
Elongated streams of plasma zipped back and forth along magnetic field lines above several active regions on the…